Context: The ongoing Covid-19 pandemic and the global race to develop a reliable vaccine, with attendant concerns about ‘vaccine nationalism’, have reinforced the importance of investing in domestic research and development (R&D).
Achievement of Pharmaceutical Sector of India:
Steps to improve the Pharmaceutical Sector:
Conclusion: It is incumbent upon government to provide competitive space to Indian Pharmaceutical firms by ensuring efficient regulation that is sensitive to cost and time requirements of firms investing in R&D.